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Keratinocyte (KC) gene expression is regulated by members of the nuclear receptor (NR) superfamily including
retinoic acid receptors, retinoid X receptors (RAR and RXR, respectively), and peroxisome proliferator activated
receptors (PPAR). In addition to ligand, NR transcriptional activity is controlled by interaction with proteins, col-
lectively known as coregulators, which function as corepressors or coactivators. To improve our understanding of
coregulators expressed in epidermis, we screened a KC cDNA library for PPARa-interacting proteins. The screen
yielded previously unknown proteins including one we named COPR1, for comodulator of PPAR and RXR. COPR1
and its longer variant COPR2 target the AF-2 domains of NR but exhibit quantitative differences in their functional
interactions with RAR, RXRa and PPAR. They decrease but do not completely repress the activity of RXRa and
PPARa because of a proline-acid-rich autonomous activation domain. An NR box motif contributes to but is not
solely responsible for functional and physical association with RXRa. The activation domain, their relatively small
size (COPR1, 26.9 kDa; COPR2, 32.4 kDa), and strict dependence on AF-2 for interaction distinguish COPR1 and
COPR2 from the SMRT/NCoR type of corepressor and may represent a means of control that dampens rather than
completely represses NR-mediated gene expression.
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Nuclear receptors (NR) act in concert with their respective
ligands and an increasing repertoire of coregulator proteins
to govern gene expression affecting basic metabolic proc-
esses as well as differentiation-specific promoter activity.
Coregulator proteins are broadly separated into coactivator
and corepressor groups (Rosenfeld and Glass, 2001 for a
review). NR–coregulator interactions (McInerney et al, 1998)
are dependent on conserved amino acid motifs in the re-
ceptor carboxyl terminus (ffXEff; f¼hydrophobic amino
acid, X¼ any amino acid, E¼glutamic acid). Within coac-
tivators, a corresponding interaction site for the receptor,
termed an NR box, has been identified as a leucine rich,
short amphipathic helix (LXXLL, L¼ leucine). Recent re-
ports, however, demonstrate that the LXXLL motif may be
coopted for interaction with NR by corepressors (Delage-
Mourroux et al, 2000; Moraitis et al, 2002; Fernandes et al,
2003). Thus, cell-specific expression of NR and coregula-
tors, as well as availability of ligand, contributes to the
combinatorial gene regulation responsible for particular re-
sponses to receptor ligands. Identifying NR coregulator
proteins in ligand-responsive tissues should provide better
understanding of NR function.
Epidermal keratinocytes (KC) are responsive to ligands
for several NR including retinoids and peroxisome prolif-
erators (Hanley et al, 1998; Rivier et al, 1998; Aneskievich,
2001 and references therein). Retinoic acid receptors (RAR),
retinoid X receptors (RXR), and peroxisome proliferator ac-
tivated receptors (PPAR) have been separately implicated in
epidermal maintenance, malignancy, and wound healing
(Aneskievich and Fuchs, 1992; Aneskievich and Fuchs,
1995; Feng et al, 1997 for examples; Michalik et al, 2001).
Activation of PPARa in epidermal KC results in increased
differentiation and barrier function (Hanley et al, 1998; Rivier
et al, 1998). As the heterodimer partner for both RAR and
PPAR, RXR serves as an important cross-point for regula-
tion of these Class I NR (Rosenfeld and Glass, 2001 for a
review). Thus there is the potential for any one coregulator
to influence the function of several NR whether through di-
rect interaction with that NR or via interaction with the
common heterodimer partner RXRa.
Although the NR function is dependent on interaction
with coregulator proteins, their expression in KC has yet
to be thoroughly examined. To directly address this, we
screened a KC cDNA library with the ligand-binding domain
of human PPARa (huPPARa-DEF), using yeast two hybrid. In
addition to known PPARa-interacting proteins (Li and An-
eskievich, data not shown) such as RXRb, NCoR2, and
TRAP220/PBP, the screen yielded several clones for as yet
unidentified proteins or known proteins not yet character-
The nucleotide sequences reported in this paper have been
submitted to GenBank as COPR1 and COPR2 and assigned ac-
cession numbers AY267839 and AY267840, respectively.
Abbreviations: A, alanine; AAD, autonomous activation domain;
AD, fusion vector activation domain; AF-2, activating function 2
domain; BD, fusion vector DNA-binding domain; CAT, chloramp-
henicol acetyltransferase; COPR, comodulator of PPAR, RXR; F,
phenylalanine; HA, hemagglutinin; KC, keratinocyte; L, leucine; NR,
nuclear receptor; P, proline; PP, peroxisome proliferator; PPAR, PP
activated receptor; RAR, retinoic acid receptor; RXR, retinoid X
receptor; X, any amino acid; Y, tyrosine
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ized for their interaction with NR. Here we report the
isolation and analysis of COPR1, a previously unknown
comodulator of PPAR and RXRa. COPR1 is related to a
known nuclear receptor-binding factor identified from rat
liver and named NRBF-2 (Yasumo et al, 2000). We charac-
terized a human homologue to rat NRBF-2 and will refer to it
as COPR2 given the results of sequence and functional
comparison with COPR1. COPR1 and COPR2 are appar-
ently derived by variant splicing of the same transcript re-
sulting in a 50 amino acid difference between the respective
proteins. COPR1 and COPR2 indicate the shorter and long-
er isoforms, respectively. Their relatively small size (26.9 and
32.4 kDa, respectively, for COPR1 and COPR2) distinguish-
es them from the more numerous p160 coregulator family.
For COPR1 and COPR2, an LLYLL (Y¼ tyrosine) motif
matching the LXXLL NR box consensus was required for
efficient functional interaction with the NR tested. The
LXXLL motif is typically characteristic of coactivators (Rose-
nfeld and Glass, 2001 for a review); however, COPR1 and
COPR2 decrease receptor function adding them to a select
subset of LXXLL-mediated corepressors such as Hr (hair-
less), REA (repressor of estrogen receptor activity), and
LCoR (ligand-dependent corepressor) (Delage-Mourroux
et al, 2000; Moraitis et al, 2002; Fernandes et al, 2003).
Distinct from these three, however, COPR1 and COPR2
each have an autonomous activation domain (AAD) and
thus do not completely repress NR activity. Given these re-
sults and in the context of previously characterized NR co-
regulators, we suggest COPR1 and COPR2 add to the small
subset of LXXLL-utilizing corepressors, but with the unique
feature of dampening instead of completely repressing
liganded NR. Such regulation allows for finer incremental
control of ligand-induced transcriptional activity.
Results
Cloning of COPR1 We screened a yeast two-hybrid-based
human KC cDNA library with the ligand-binding domain of
huPPARa. Several clones passed the interaction-dependent
selection criteria of a-galactosidase expression and growth
on two independent nutritional selection markers (see
Materials and Methods). One clone, ultimately designated
COPR1, was a complete cDNA (Fig 1) and possessed an
NR box (LLYLL) characteristic of NR coregulators. Unex-
pectedly, COPR1 was capable of functioning in the yeast
two-hybrid screen independent of its production as a
fusion with the pGAD10 Gal4 activation domain (AD).
Nucleotide sequence analysis revealed that the longest
contiguous reading frame of the insert was anti-sense rel-
ative to the vector AD coding region. Further analysis of the
vector backbone revealed a cryptic promoter downstream
of the insert (Chien et al, 1991) responsible for expression.
These findings suggested that the COPR1 protein had an
AAD capable of functionally replacing the AD otherwise
provided from the plasmid Gal4 coding sequences. This
was later confirmed experimentally (see localization studies
below).
Sequence and motif analysis of COPR1 Sequencing of
the COPR1 insert revealed a complete cDNA as judged by
an ATG codon (nucleotides 113–115) in a Kozak consensus
sequence (TCT-ATG-G matching consensus YNN-ATG-G), a
contiguous coding region predicting a protein of 237 amino
acids, an in-frame stop codon TAA (nucleotides 824–826),
consensus polyA signal (AATAAA, nucleotides 1613–1618),
and the beginning of a polyA tail (Fig S1). A predicted mo-
lecular weight of 26.9 kDa makes COPR1 distinct as one of
the smaller NR coregulators isolated to date and likely dif-
ferent from the better-characterized p160 group. COPR1
has one predicted NR box at amino acid residues 91–95
(Fig S1 and Fig S1b). The NR box, a motif of LXXLL amino
acid residues, is necessary and sufficient to initiate coreg-
ulator–NR interaction (McInerney et al, 1998; Schaufele et al,
2000). PHD, a web-based neural-network analysis program,
predicted a leucine zipper overlapping L128-L156 (five he-
ptad repeats, Fig S1), which was characterized and will be
reported elsewhere. For this report we will focus on COPR1,
Figure 1
cDNA and protein sequences for COPR1 and COPR2. BLAST comparison with dashes inserted to achieve maximum alignment. Outside the 150
nucleotide region, the predicted translation for COPR1 (upper sequence) and COPR2 (lower sequence) is identical. Leucine zipper and proline-acid-
rich (PAR) domains are indicated by zigzag and double underlines, respectively. Leucines targeted by site-directed mutagenesis for the 2,3 zipper
mutant are shown in reverse print. Locations of early stop 1 and 2 C-terminal truncations (ES1 and ES2) are indicated by vertical lines through the
sequence. nuclear receptor box sequence, LLYLL, is bold and underlined. The asterisk denotes the stop codon. COPR1 and COPR2 have GenBank
accession numbers AY267839 and AY267840, respectively.
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its homology to a known NR coregulator, and a comparison
of the two for their interaction with specific NR.
A GenBank BLAST search revealed the best homology in
the non-redundant database to a clone for a NRBF-2 iso-
lated from a rat liver cDNA library using mouse PPARa (Ya-
sumo et al, 2000). Alignment of the predicted amino acid
sequences from human KC-derived COPR1 and the rat liver
clone revealed contiguous extra 50 amino acids central to
the rat clone in addition to 13 scattered amino acid differ-
ences. To determine if this 50 amino acid region is a spe-
cies-specific difference, we searched the GenBank EST
database for a human cDNA clone that would also encode
the extra 50 amino acids. The best matching clone (EST
#178080) was sequenced and found to contain a coding
region identical to our COPR1 clone except for the insertion
of 150 additional nucleotides. Comparison of the predicted
amino acids for this human clone and the published rat
sequence shows 14 substitutions, four of them conserva-
tive. Although the rat clone (Yasumo et al, 2000) was named
NRBF-2, no direct physical association with NR was dem-
onstrated, nor was COPR1 detected. From our analysis of
their individual characteristics, effects on NR function, and
related transcript origin we suggest the names COPR1 and
COPR2 for the smaller and larger proteins, respectively.
Thus, COPR2 is the human homologue of the rat NRBF-2.
All subsequent analysis will be from the two human clones
we have derived.
Predicted amino acid sequences for COPR1 and COPR2
are shown in Fig S1. Secondary structure analysis predicts
an extended 35 amino acid helical region terminating with
the LLYLL of COPR1 (Fig S1b). In contrast, the 50 amino
acid insertion in COPR2 results in a mixed region of short
helices, non-helical stretches, and a potential loop imme-
diately amino to its LLYLL (see relative assignment values in
Fig S1b). Given that amino acids flanking the LXXLL motif
are integral in determining specificity and strength of co-
regulator/NR interactions (McInerney et al, 1998 for exam-
ple), we expected that these two variants could have
different biological activities.
Expression and genomic analysis The basis for the
COPR1 and COPR2 cDNA difference was examined (Fig
S2) at the levels of mRNA, commercially prepared cDNA,
genomic DNA, and high throughput genomic sequence
databases. Primers flanking the diversity region (Fig S2a
arrowheads) and with sequence in common to COPR1 and
COPR2 were used in RT-PCR of total RNA isolated from
human normal KC, MCF-7 cells (breast cancer epithelial
line) or HaCaT cells (non-tumorigenic, immortalized KC).
Two bands of the sizes predicted from the cDNA sequences
for COPR1 and COPR2 (643 and 794 base pairs (bp), re-
spectively, Fig S2b) were obtained from the normal KC and
MCF-7 cells. HaCaT KC expressed COPR2 only. The sig-
nificance of this difference is unresolved. Both forms could
be detected with primers (Fig S2a, arrows) and PCR of the
normal KC cDNA library used for the two-hybrid screen.
COPR1 and COPR2 were also detected in a cDNA panel
derived from normal tissues (Fig S2c) although in very dif-
ferent amounts. The 150 bp size difference of the corre-
sponding transcripts would not have been detected by the
northern analysis used in the partial characterization of the
rat NRBF-2 clone (Yasumo et al, 2000).
The extensive sequence identity shared by COPR1 and
COPR2 suggested they are derived from the same tran-
script with alternative splicing accounting for the 150 nuc-
leotide region difference. PCR using human genomic DNA
produced only one band of a size matching a contiguous
stretch including the 150 bp difference of the two isoforms
(Fig S2d). Production of one band is consistent with the idea
that subsequent to alternative splicing, the transcript of one
gene could account for the two cDNA. BLAST alignments of
COPR1 and COPR2 cDNA were done against the human
genome sequence. A match for both occurred with 99%–
100% identity on the same region of chromosome 10 with
interrupted sequences suggesting intron/exon boundaries.
By consideration of potential splice donor–acceptor se-
quences (Modrek and Lee, 2002 for a review) four exons
(I–IV) and three introns (i–iii) that agree with canonical
exon/intron boundaries (Table I) were recognized. The 150
Table I. Summary of predicted splicing boundaries and product sizes
Exon number, size 50 splice sequence 30 splice sequence Intron #, size
Standard splice
I, 421 ACCTGgtgaga i, 12,991
II, 83 tctagGCTCA TGCAGgtgag ii, 5855
III, 39 aacagCATAT AGCAGgtgag iii, 1321
IV, 4707 aatagGCTCA





aCapitals, coding sequence; lower case intron for standard exon/intron boundaries.
bItalics, nucleotides matching repeat sequences flanking variant splice region.
cDouble underline, dinucleotides complimentary between the first and second repeat.
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nucleotides comprising the difference between the COPR1
and COPR2 cDNA are flanked by direct repeats of 12 bp
with high identity (11/12) and potentially similar function to
the direct repeats that give rise to variant mRNA splicing for
mdm2 (Bartel et al, 2002 and references therein).
Identiﬁcation and localization of an AAD in COPR1 and
COPR2 Nucleotide sequencing of the COPR1 clone re-
vealed that it could not form a fusion protein with the yeast
plasmid vector Gal4 AD suggesting the activation function
required for transcription in the two-hybrid screen was being
provided from its own coding sequence. AAD would likely
impact on the function of COPR1 and/or COPR2 as NR co-
regulators and had been suggested from the characterization
of the larger isoform isolated from rat (Yasumo et al, 2000). To
test for an AAD, the cDNA of COPR1 and COPR2 were in-
dividually fused in-frame to the Gal4 DNA-binding domain of
the mammalian expression vector pM. Both COPR1 and
COPR2 were able to provide a transcriptional activation
function in cis in this system indicative of an AAD (Fig S3a).
The COPR2 isoform showed approximately 2-fold higher
activity than COPR1. Transfected cells produced similar lev-
els of COPR1 and COPR2 protein (not shown). These acti-
vation levels are on par with the well characterized, high level
transcriptional activation derived in this system seen with
the SV40 T antigen-p53 control. Similar COPR1 and COPR2
Gal4 DNA-binding domain fusions were made in pGBKT7
for testing in a yeast one-hybrid system. Again, COPR2
showed approximately 2-fold higher activity (Fig S3b).
Given the similar results with the yeast system and the
advantage of its simpler experimental design, we continued
to use it for localizing the AAD of COPR1 and COPR2. Two
carboxyl-terminal truncations (early stop codon, ES1 and
ES2) and a leucine zipper mutant (2,3Z) of each COPR
isoform (Fig S3c) were generated and tested for their tran-
scriptional activation ability relative to the wild-type form in
the Gal4 DNA-binding domain yeast vector pGBKT7. COP-
R1 and COPR2 each lost over 95% of their activation func-
tion concurrent with the carboxyl deletion of the leucine
zipper and proline-acid-rich domain (ES1) or the proline-
acid-rich domain (ES2) alone, suggesting that most of the
AAD was indeed contained in this extreme carboxyl-termi-
nal region (Fig S3d). It is unlikely the predicted leucine zip-
per region is recruiting transcription activating proteins to
the reporter promoter. COPR1 and COPR2 mutants where
leucines in the second and third ‘‘d’’ positions of the zipper
(2,3Z) were replaced with alanine (Fig S3c) had a statistically
significant increase in reporter activity (Fig S3d) compared
with the wild-type form (t test po0.05). Mutagenesis of
consecutive ‘‘d’’ position leucines eliminates or severely re-
duces leucine zipper-mediated protein interaction in other
NR coregulators (Li et al, 2001 for example). The alanine
replacements in the leucine zipper consensus of COPR1
and COPR2 are conservative substitutions but may have
disrupted a cis repression domain. The occurrence of an
AAD and an autonomous repression domain in the same NR
coregulator has precedence from the analysis of the RXR
coregulator NRIF (Li et al, 2001 for example).
NR interaction with COPR1 and COPR2 COPR1 was iso-
lated from a human KC cDNA library by interaction with the
huPPARa-DEF subdomains. We have found the COPR1
cDNA represented in other clones passing the screening
criteria of prototrophy for two nutritional markers and ac-
tivating the MEL1-driven a-gal reporter. There have not
been any clones isolated for the COPR2 form, however,
even though this cDNA is represented in the KC library (see
Fig S2c, lane KCL). This observation suggested a potential
difference in the interaction of COPR1 and COPR2 with
PPARa and other NR expressed in KC such as other PPAR
isoforms, RXRa, RARa, and RARg.
We used a yeast two-hybrid system (Fig S4) to compare
the relative interaction of COPR1 and COPR2 with NR in the
presence or absence of exogenous ligand using concen-
trations the same as or lower than those previously reported
for each of the PPAR (Monden et al, 1999; Kodera et al,
2000; Lampen et al, 2001; Hao et al, 2002; Krogsdam et al,
2002; Sumanasekera et al, 2003) in similar studies. Ligand
effect on the interaction of COPR1 and COPR2 with the
different PPAR was receptor specific. Their interaction with
liganded PPAR was reduced for a but enhanced with d and
g. For each receptor, the COPR1 isoform typically showed
greater change due to ligand. Also, the COPR1 isoform had
greater functional interaction with PPARa than COPR2. This
preference for the COPR1 coregulator also held for PPARd
and PPARg. For example, COPR1:PPARg interactions yield-
ed eight to 10 times more reporter activity than COP-
R2:PPARg. The consistently lower functionality of COPR2
with PPARamay explain why it was not isolated from the KC
cDNA library where it would have to complement several
selection markers driven by distinct promoters. This was
formally tested by culture assays on solid media to compare
the ability of COPR1 versus COPR2 to interact with PPARa
and thus rescue growth (Fig S5). Only COPR1 supported
efficient growth with the PPAR-DEF constructs on the
selection media used for the original two-hybrid screen.
This quadruple drop-out media provides stringent selection
against relatively weaker interactions.
In contrast to the PPARa results, all retinoid receptor
functional interactions with COPR1 (and for COPR2 with
RXRa) were enhanced by ligand (Fig 2). COPR2 had no
significant functional interaction with the RAR in control
media or 1 mM all trans-RA-treated cultures. The striking
(4100-fold) increase in COPR1:RXRa functional interaction
due to use of 1 mM 9-cis-RA-guided selection of this re-
ceptor for additional analysis (see Figs S6 and 3). Thus,
receptor preference for interaction with either COPR ex-
tends beyond the PPAR to retinoid NR where for COPR1 it is
uniformly enhanced by ligand. Although they are small re-
lated proteins with only one predicted NR box, COPR1 and
COPR2 have complex ligand-regulated and selective inter-
actions for NR relevant to KC.
Interaction of COPR1 and COPR2 with NR is NR box-
dependent Protein–protein interaction between NR and
coregulators is ultimately mediated by their three-dimen-
sional conformations although relatively short amino acid
motifs in each are known to be critical to the overall struc-
tural interaction (Rosenfeld and Glass, 2001 for a review).
The cDNA sequences of both COPR1 and COPR2 predict a
motif of LLYLL, conforming to the LXXLL motif established
as the NR box (McInerney et al, 1998; Schaufele et al, 2000).
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We examined the LLYLL motif in COPR1 and COPR2 in
regard to interaction with two NR, PPARa, and RXRa. For
these NR, interaction with the coregulators had been
strongest yet oppositely affected by ligand (decreased with
PPARa, increased with RXRa). When the LLYLL motif of
COPR1 and COPR2 was converted to LLYAA (A¼ alanine)
by site-directed mutagenesis, there was a decrease in
reporter activity (Fig S6) for both PPARa and RXRa under
the relevant ligand conditions. Although COPR1 and COP-
R2 had distinct preferences for unliganded PPARa and
liganded RXRa, in each instance the LLYLL NR box facil-
itated the interaction. Although starting with lower activity,
the COPR2:PPARa association was also reduced by the
LLYLL ! LLYAA mutation.
The interactions of COPR1 and COPR2 with RXRa are
distinct from their interaction with PPARa in that functional
interaction is greatly facilitated by the presence of RXRa
ligand 9-cis RA. Over 95% of the ligand-dependent inter-
action of COPR1 and RXRa could be lost by introducing
the LLYLL ! LLYAA mutation (Fig S6). For both COPR1 and
COPR2, however, the LLYLL ! LLYAA mutation did not
completely abolish RXRa interaction in the presence of lig-
and (Fig S6, compared with lamin C negative controls). This
remaining activity suggests these coregulators might harbor
some other motif contributing to overall interaction with
certain NR.
Interaction of COPR1 and COPR2 with RXRa and PPARa
is AF-2 dependent The interaction site for several coreg-
ulators has been mapped to the AF-2 region of NR (Rose-
nfeld and Glass, 2001; Moraitis et al, 2002). We investigated
the role of AF-2 in the NR that demonstrated the best
Figure 3
In vivo COPR1 and COPR2 interaction with RXRa and PPARa is AF-
2 dependent. (a) Yeast two-hybrid b-galactosidase activity was deter-
mined as in Fig S3 following coexpression of either pGAD10 containing
COPR1 or COPR2 with pGBKT7 containing RXRa wild-type (WT), the
double alanine RXRa AF-2 mutant (AA) or lamin C as a negative control
(Lam). Yeast were grown with vehicle (DMSO, final concentration 0.1%,
bars) or 9-cis RA (1 mM, þbars). (b) Mammalian two-hybrid analysis.
COS-7 cells were cotransfected with pM vector expressing RXRa wild-
type or AF-2 double alanine mutants (WT and AA, respectively) and
pVP16 vector with no insert (long dash) or expressing COPR1 or COP-
R2 WT or NR box mutant LLYAA (AA). Cultures received vehicle (,
DMSO, 0.1%, open bars) or 9-cis RA (þ , 1 mM, solid bars). Activity of
the pM-RXRa fusion in the presence of ligand was set for relative
comparison at 100%. (c) Yeast two-hybrid b-galactosidase activity was
determined as in Fig S4 following coexpression of either COPR1 or
COPR2 WT or LLYAA mutants (WT and AA, respectively) from pGAD10
with PPARa WT, PPARa AF-2 double alanine mutant (AA) or lamin C
(Lam). Since ligand decreases interaction of these coregulators with
PPARa, all samples were cultured in standard media. (a–c) SDp10% of
the mean are not shown.
Figure 2
COPR1:RXRa (retinoid X receptors) interaction predominates
among COPR1/COPR2 interaction with retinoid receptors. Yeast
two-hybrid b-galactosidase activity was determined as in Fig S4. Cul-
tures were supplemented with vehicle (DM, DMSO, final concentration
0.1%) or ligand (LG), 1 mM all-trans RA for retinoic acid receptors
(RAR)a and g, and 1 mM 9-cis RA for RXRa. The break and scale change
in the ordinate axis accommodate high activity from the COPR1:RXRa
interaction in the presence of ligand.
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interaction with COPR1 and COPR2, specifically, liganded
RXRa and unliganded PPARa. For each of these receptors,
alanine substitutions were introduced to replace two con-
served large hydrophobic amino acids required for AF-2
function (Treuter et al, 1998; Thompson et al, 2001). The
high activity seen with COPR1, ligand, and wild-type RXRa
was decreased to near background levels with the FL 450,
451 AA RXRa mutant (Fig 3a). Although starting at a lower
level than COPR1, COPR2:RXRa interaction was also de-
creased with the receptor mutant.
We confirmed these yeast analyses by performing mam-
malian two-hybrid studies. Figure 3b shows ligand-depend-
ent interaction of COPR1 and COPR2 with RXRa, with little
interaction in the vehicle control cultures. As in the yeast,
COPR1 had better interaction than COPR2 with RXRa gen-
erating  4-fold more activation of the reporter than re-
ceptor fusion alone in the presence of 9-cis RA. For both
COPR1 and COPR2 the LLYLL ! LLYAA NR box mutation
reduces but does not completely eliminate the 9-cis RA-
enhanced interaction. The FL450, 451AA AF-2 RXRamutant
had no detectable interaction. These data again support the
existence of two domains in COPR1 and COPR2, but only
one in RXRa, mediating their interaction.
NR box mutation in COPR1 and COPR2 also decreased
their interaction with PPARa (Fig 3c, bars at left). An AF-2
mutation in PPARa, LL459, 460AA completely abolished
in vivo interaction (Fig 3c, center bars) with either core-
gulator. Thus, functional interaction of either COPR1 or
COPR2 with RXRa and PPARa appears to occur via a bona
ﬁde NR box (LLYLL) and the receptor AF-2 helix.
COPR1 and COPR2 repress NR transactivation The two-
hybrid assays established interaction of COPR1 and COP-
R2 with several NR. We focused on RXRa to examine the
effect COPR1 or COPR2 might have on its transcriptional
activity. Mammalian expression vectors with wild-type or
LLYLL ! LLYAA mutants of COPR1 or COPR2 were cot-
ransfected into HaCaT KC with a reporter construct bearing
a retinoid X response element (Mangelsdorf et al, 1991) (Fig
4). HaCaT cells have been previously used as a model sys-
tem to study KC differentiation (Schoop et al, 1999) and
activity of different NR (Inui et al, 1999; Kippenberger et al,
2001; Westergaard et al, 2003). Both COPR1 and COPR2
could partially repress endogenous RXR activity in HaCaT
cells in vehicle- and 9 cis-RA-supplemented media. For
COPR1, some, but not all, repression could be eliminated
by mutation of the LLYLL motif to LLYAA (Fig 4 compare WT
with AA bars). A similar decrease in RXR activity occurred
with COPR2 expression; however, mutation of the COPR2
LLYLL NR box had no effect. This may be due to the 50
amino acid insert which positions the NR box in a locally
different peptide environment.
RXRa functions as the heterodimer partner for several
NR including PPARa to drive expression from target pro-
moters. We found coexpression of PPARa and RXRa could
drive activity of an involucrin promoter reporter construct in
COS-7 cells (Fig S7). This system is based on findings from
Banks et al (1999) regarding the sensitivity of the involucrin
promoter to specific transcription factors ectopically ex-
pressed in non-epidermal cells. With coexpression of PPARa
and RXRa, we noted promoter activity in vehicle-treated
cultures that may result from PPARa-activating compounds
such as fatty acids in the serum-supplemented media.
Next, involucrin promoter activity could be enhanced by
addition of exogenous ligand for PPARa consistent with a
previous demonstration (Hanley et al, 1998, 2000) of pos-
itive regulation of involucrin expression by PPARa. Expres-
sion of COPR1 decreased the involucrin promoter activity in
ligand-treated cells coexpressing PPARa-RXRa by about
70%. A statistically significant (t test, po0.001) amount of
this repression could be relieved in both vehicle- and ligand-
treated cultures by mutation of the COPR1 NR box (Fig S7,
compare rightmost pairs of bars for WT vs AA mutant). This
partial recovery supports the premise of a second NR-
directed interaction domain in the COPR1 coregulator. In
addition, the COPR1 LLYAA mutation partially restored (t
test, po0.005) liganded PPARa function (Fig S7, compare
open to striped bars, vehicle vs WY-treated cultures, re-
spectively, for AA set rightmost in graph).
COPR1 and COPR2 physically associate with
RXRa Yeast and mammalian two-hybrid assays demon-
strated a working preference of COPR1 and COPR2 for
RXRa. Thus we focused on this NR for studies of how the
LLYLL ! LLYAA mutation, the RXRa AF-2 mutation, and the
presence of ligand might affect physical association during
‘‘pull-down’’ assays. The amount of myc-RXRa retrieved by
coprecipitation was normalized (see Materials and Methods
for image analysis details) to the amount of hemagglutinin
Figure4
Functional effect of COPR1 and COPR2 on RXRa. HaCaT keratin-
ocytes were cotransfected with RXRE-tk-CAT and wild-type (WT) or NR
box double alanine (AA) mutants of COPR1 or COPR2 in the mamma-
lian expression vector pcDNA3.1þ . Activation of the reporter was de-
pendent on endogenous RXR. A CMV-b-gal plasmid was included as
an internal transfection normalization control. Cultures were grown in
vehicle- (0.1% DMSO, final concentration) or ligand-supplemented (1
mM 9-cis RA) media. Tukey’s test following one-way ANOVA was sep-
arately performed for vehicle and 9-cis RA-supplemented sets of cul-
tures. For each set, bar values with different letters (vehicle a, b or c; 9-
cis RA x, y or z) are significantly different from others in that set at
po0.05. Data presented are the means  SD of triplicate samples and
are representative of at least two independent transfections.
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(HA)-tagged coregulator in the precipitation complex (Fig
S8). Both coregulators could bind to RXRa with out addition
of 9-cis RA. This association was decreased by 70%–80%
by addition of ligand. The LLYLL ! LLYAA mutation in
COPR1 but not COPR2 showed some loss ( 25%) of as-
sociation with the wild-type RXRa. These results mirrored
the effect of the LXXLL mutation seen in the RXRE-tk-CAT
reporter assays where mutation of COPR1 but not COPR2
could alleviate some of the coregulator repression of RXRa
transcriptional activity. The AF-2 mutation in RXRa reduced
its physical association with COPR1 and COPR2 by over
90%, paralleling the loss of functional interaction with the
same mutant receptor seen in the yeast and mammalian
two-hybrid assays (Fig 3a and b).
Discussion
To identify NR coregulators from human epidermis, we used
the ligand-binding domain of huPPARa in a yeast two-hy-
brid screen of a KC cDNA expression library that yielded a
previously unknown NR coregulator we named COPR1.
COPR1 is related to a larger isoform, designated COPR2 in
this report, and previously termed NRBF-2 by Yasumo et al
(2000). Similar to some other NR coregulators (Kalkhoven
et al, 1998; Li et al, 2001), COPR1 and COPR2 are appar-
ently derived from variant splicing of one transcript. We ex-
amined their functional association not only with PPAR but
also with retinoid receptors relevant to KC physiology. Di-
rect comparison of six NR (PPARa, d, g, RARa, g, and RXRa)
in control and ligand-supplemented yeast two-hybrid stud-
ies showed the best COPR1 and COPR2 interaction with
holo-RXRa followed by apo-PPARa. COPR1 and COPR2
association with these two receptors is partially dependent
on the coregulator LLYLL NR box and completely depend-
ent on the receptor AF-2. The same studies demonstrated
COPR1 had consistently better functional interaction than
COPR2 with the NR tested. This performance difference
may be due to the 50 amino acid insert occurring in COPR2
immediately prior to its LLYLL NR box. The insert contains
non-helical and loop regions that may disrupt the otherwise
contiguous sequence of helical domains immediately amino
to the LLYLL NR box in COPR1.
COPR1 and COPR2 exhibit NR box-mediated interaction
with the AF-2 domain of RXRa, predictive of their function
as NR coactivators; however, they act as partial repressors
of RXR activity in HaCaT cells. NR box-mediated repression
is unexpected although not without precedent. Repressor of
estrogen receptor activity (REA) (Delage-Mourroux et al,
2000), hairless (Hr) (Moraitis et al, 2002), and ligand-
dependent corepressor (LCoR) (Fernandes et al, 2003) are
corepressors. Like COPR1 and COPR2, they exert part of
their functional effect through LXXLL motifs targeting re-
ceptor AF-2 regions. Distinct from these three, repression of
RXRa activity by COPR1 or COPR2 coexpression is not
complete, potentially due to the presence of the COPR
AAD. By targeting RXRa, COPR1 and COPR2 may be able
to limit transcriptional activity of RXRa homo- and het-
erodimers.
Given their corepression of RXRa, COPR1 and to a lesser
extent COPR2 may have wide-ranging effects on KC biol-
ogy and differentiation. Recombinant technologies gener-
ating PPAR-deficient mice or epidermis-specific RXRa
knockouts as well as ligand studies for PPAR, FXR, and
LXR have shown a role for these receptors in cutaneous
wound healing, inflammatory responses, and overall epi-
dermal maintenance and maturation (Hanley et al, 1997; Li
et al, 2001; Michalik et al, 2001; Westergaard et al, 2001;
Fowler et al, 2003; Westergaard et al, 2003). As with other
ligand-sensitive cells (Rosenfeld and Glass, 2001), KC
physiology under conditions of ligand absence or presence
is dependent on more than receptor expression alone. In
this context, recent studies in KC have begun to address
the contribution of known coregulators such as CBP (West-
ergaard et al, 2003) and p/CAF (Kawabata et al, 2001). As
with these transcriptional regulators, expression of COPR1
and COPR2 is not tissue restricted but, nevertheless, could
contribute to the combinatorial control of NR involved in KC
physiology. In this report, we focused on functional effects
of COPR1 and COPR2 on RXRa given its ability to control
gene expression by homodimerization and heterodimerizat-
ion with relevant partners such as PPARa. Control of RXRa
transcriptional activity is still an incompletely understood
process. Relative to RXRa’s potential heterodimer partners,
its interaction with corepressors such as SMRT (Zhang et al,
1999) and NCoR (Seol et al, 1996) is weaker. Thus, the
presence of helix 12-dependent corepressors such as
COPR1 and COPR2 may provide a means of receptor reg-
ulation that complement the otherwise limited RXR-directed
repression by other coregulators. The ability of COPR1 and
COPR2 to exert their repressive effect in the presence of
ligand may alter transcriptional activity of a multitude of KC-
relevant, RXR-associating NR that contribute toward prolif-
eration, differentiation, and barrier formation.
COPR and REA both display separable physical and
functional interactions with NR regarding the LXXLL motif.
The one LXXLL NR box of REA is not needed for physical
interaction with ER (Delage-Mourroux et al, 2000); however,
it is required for optimal functional effect, i.e., repression of
ER. Delage-Mourroux et al (2000) concluded that non-
LXXLL motifs may be responsible for the physical associ-
ation whereas the LXXLL is necessary for a final protein
configuration, which mediates the repression. Coimmuno-
precipitation, two-hybrid, and reporter transactivation re-
sults support the existence of another interaction motif in
COPR potentially working in conjunction with the LLYLL NR
box for interaction with RXRa. An extended leucine motif
(LKGPIEKEL) occurs in both COPR1 and COPR2 and
matches a consensus sequence (LXXXI/LXXXL) found in
other coregulators and designated the repressor interaction
domain (Rosenfeld and Glass, 2001). The dual presence of
LXXLL NR boxes and LXXXI/LXXXL repressor interaction
domains in the same protein is exemplified by Hr, where
they may contribute to its differential interaction with mul-
tiple NR (Potter et al, 2001; Moraitis et al, 2002).
In summary, our results demonstrate that COPR1 and
COPR2 join the small but growing subset of corepressors
that utilize the LXXLL NR box, otherwise associated with
coactivators, to interact with NR. The ability of LXXLL-me-
diated corepressors to interact with NR in the presence of
ligand and repress receptor function distinguish them from
typical corepressors such as SMRT, which repress NR
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function in the absence of ligand. COPR1 and COPR2,
along with corepressors such as LCoR, may allow for a
submaximal response during instances of inappropriately
timed or excess ligand exposure. Notably, because of their
AAD, COPR1 and COPR2 remain distinct from these other
LXXLL-mediated corepressors and provide a means, at
least for RXRa, to blunt but not completely silence receptor
function.
Materials and Methods
Yeast two-hybrid screening The huPPARa-DEF subdomain (ami-
no acids 167–468 in pGBKT7) was used to screen a human KC
cDNA library (Clontech, Palo Alto, California) in plasmid pGAD10
(  5  106 independent clones). AH109 yeast transformed with
pGBKT7-huPPARa-DEF showed no autonomous activation of re-
porter genes and were secondarily transformed with library plasm-
ids followed by selection for fusion protein interaction on -Leu/-
Trp/-His plates. The equivalent of 12  106 secondary transform-
ants was screened. Leuþ /Trpþ /Hisþ colonies were subjected to
additional interaction selections by complementation of the AH109
Ade phenotype and activation of MEL1 (a-galactosidase report-
er). Several clones passing interaction selection criteria (Hisþ /
Adeþ /Melþ ) contained complete cDNA and one of these, ulti-
mately designated COPR1, was selected for further analysis.
b-galactosidase activity was normalized to yeast cell number and
length of reaction time (Miller units). Each assay was performed
two to three times with triplicate samples for each test.
Plasmids Fusions of human NR carboxyl regions and Gal4 BD
were made by subcloning PCR generated (Pfu: Stratagene, La
Jolla, California) cDNA into yeast (pGBKT7) or mammalian (pM)
expression vectors (Clontech). PCR-generated constructs and
site-directed mutants of human NR in Table II (QuikChange, Stra-
tagene) were verified by nucleotide sequencing. Primer sequences
for the receptor constructs and mutagenesis are available upon
request. Recombinant DNA procedures were approved by the In-
stitutional Biosafety Committee, University of Connecticut.
Genomic and EST clone analysis Four regions of identity to
COPR were localized to a genomic clone RP11-144G16 derived
from chromosome 10 (AL590502). Intron–exon boundaries were
determined in silico following published criteria (Bartel et al, 2002;
Modrek and Lee, 2002). A full-length cDNA for COPR2 was iden-
tified from the EST database (#178080), obtained from ATCC
(Manassas, Virginia) (#108720) and sequenced on both strands.
The three nucleotide difference of COPR1 and COPR2 in the 30
non-coding region also occurs in other GenBank deposits and is
likely due to isolation from different donor samples.
Multiple tissue cDNA panel PCR PCR of a human cDNA panel
(Clontech) was performed with the following cycling parameters:
initial denaturation 941C, 30 s; then 32 cycles of 941C, 30 s; 54.71C,
1 min; 721C, 1 min with primers flanking the region of diversity in
COPR1 and COPR2: forward primer 50-GCCACTACTCCCCTTCC-
TAA-30; reverse primer 50-CCTCTTTTCCCCTTTTCTGT-30. Samples
for COPR or GAPDH cDNA amplification were taken for agarose
gel electrophoresis at five cycle increments to determine a period
of linear product increase.
Cell culture, transfections, and mammalian two-hybrid as-
says COS-7 cells (ATCC) and HaCaT KC were maintained as pre-
viously described (Aneskievich and Fuchs, 1995). Transfections in
triplicate, ligand treatments, and reporter gene analysis were per-
formed as previously described (Aneskievich and Fuchs, 1995;
Aneskievich, 2001) and utilized RXRE-tk-CAT or 3700 bp derived
from the involucrin promoter (Carroll and Taichman, 1992) driving
CAT. Reporter plasmid activity for the mammalian two-hybrid as-
say readout relies on the reconstitution of a functional transcription
factor expressed as two separate modules brought together
through the physical interaction of the proteins under study to
drive expression of a reporter plasmid pG5-CAT (Luo et al, 1997).
For these experiments, COPR1 and COPR2 full-length coding re-
gion cDNA for wild-type or alanine mutant proteins were individ-
ually inserted into pVP16 (Clontech) to generate a fusion protein
with the AD of the herpes simplex virus protein. Similar to the yeast
two-hybrid system, the candidate interacting proteins, in this case
the DEF regions of wild-type or AF-2 mutant NR (see Table II), were
individually expressed as a fusion with the Gal4 DNA-binding do-
main in the vector pM (Clontech). The reporter plasmid, pG5-CAT
(Clontech), consists of five copies of the Gal4 upstream activating
sites and the adenovirus E1b minimal promoter controlling ex-
pression of CAT. COS-7 cells were transfected overnight with the
three plasmids via the calcium phosphate method, rinsed in phos-
phate-buffered saline, maintained in control or ligand supplement-
ed media for 48 h, and then assayed for CAT reporter gene
expression as previously described (Aneskievich, 2001).
Coimmunoprecipitation COS-7 cells were transfected with nor-
malized DNA amounts including carrier plasmid and mammalian
expression vector constructs for myc-tagged RXRa-DEF subdo-
mains and HA-tagged COPR1 or COPR2. Lysates (50 mM Tris-Cl,
pH 8.0, 0.5% NP-40, 120 mM NaCl) with complete protease in-
hibitors (Roche, Indianapolis, Indiana) were prepared 60 h after
transfection. All lysis and washes were performed in the presence
of vehicle or ligand as appropriate. Immunocomplexes captured
overnight at 41C on HA antibody-coupled beads (Roche) were
washed three times (20 mM Tris-Cl, pH 8.0, 0.1% NP-40, 100 mM
NaCl, 1 mM EDTA with complete protease inhibitors), eluted by
boiling in 2  Laemmli sample buffer, resolved by 10% SDS-PAGE
and transferred to nitrocellulose. Bound proteins were visualized
by chemiluminescence detected with a CCD camera in an Image
Table II. Summary of receptor subdomains in fusion constructs and site-directed mutations
Gal4BD-receptor fusion construct
Vector
Receptor subdomains aa: amino acids AF-2 amino acid substitutionsYeast Mammalian
PPARa pGBKT7 pM DEF aa 167–468 LL 459, 460 AA
PPARd pGBKT7 pM DEF aa 139–441 LL 432, 433 AA
PPARg pGBKT7 pM DEF aa 176–478 LL 468, 469 AA
RARa pGBKT7 ND DEF aa 154–462 ND
RARg pGBKT7 ND DEF aa 156–454 ND
RXRa pGBKT7 ND DEF aa 201–462 FL 450, 451 AA
DEF, nuclear receptor hinge (D) and ligand-binding carboyxl-terminus domains; L, leucine; A, alanine; F, phenylalanine; PPAR, peroxisome proliferator
activated receptors; RAR, retinoic acid receptors; RXR, retinoid X receptors; ND, not determined.
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Station 440CF. Digital signals of protein bands were analyzed with
1D Software (Kodak, Rochester, New York). Comparisons were
made after normalizing RXRa band signal to the HA-tagged COP-
R1 signal derived from the same coimmunoprecipitation lane.
We thank Dr F. J. Gonzalez for human PPARa cDNA, Dr R. M. Evans for
human RXRa cDNA, Professor Dr N. Fusenig for HaCaT cells, Dr L.
Taichman for the involucrin promoter and Rod Wilson for technical
assistance. This study was supported by University of Connecticut
Research Foundation grant E840, NIEHS grant ES07163, and NIAMS
grants AR43896 and AR48483.
Supplementary Material
The following material is available from http://www.blackwellpublish
ing.com/products/journals/suppmat/JID/JID23424/JID23424sm.htm
Figure S1
cDNA and protein sequences for COPR1 and COPR2. (a) BLAST
comparison with dashes inserted to achieve maximum alignment. Out-
side the 150 nucleotide region, the predicted translation for COPR1
(upper sequence) and COPR2 (lower sequence) is identical. Leucine
zipper and proline-acid-rich (PAR) domains are indicated by zigzag and
double underlines, respectively. Leucines targeted by site-directed
mutagenesis for the 2,3 zipper mutant are shown in reverse print. Lo-
cations of early stop 1 and 2 C-terminal truncations (ES1 and ES2)
are indicated by vertical lines through the sequence. nuclear receptor
box sequence, LLYLL, is bold and underlined. The asterisk denotes the
stop codon. COPR1 and COPR2 have GenBank accession numbers
AY267839 and AY267840, respectively. (b) PHD algorithm secondary
structure prediction for the 50 amino acid difference and adjacent ami-
no acids including the NR box. H, helical; L, loop; period, unassigned.
FigureS2
RT-PCR and PCR of COPR1 and COPR2. (a) Location of primer pairs
used for RT-PCR and PCR relative to the individual cDNA for COPR1
and COPR2. The 150 nucleotide insert in COPR2 is indicated by the
gray region in the lower cDNA. (b) RT-PCR (arrowhead primers) of RNA
derived from cultured human normal keratinocytes (KC), MCF-7 (MCF),
and HaCaT cells. , þ ; omission or inclusion of RT. DNA ladder (LD)
sizes 1000, 850, and 650 bp. Diagnostic size bands, in the two right-
most lanes (COPR1 at 643 bp and COPR2 at 794 bp) were generated
from PCR (arrowhead primers) of the cloned cDNA. (c) PCR amplifica-
tion (arrow primers) of COPR1 and COPR2 cDNA from a human mul-
tiple tissue panel. The supplier adjusts cDNA input amounts to obtain
relatively even PCR band intensities of glyceraldehyde phosphate de-
hydrogenase (GAPDH). Some tissues such as lung (LN) and skeletal
muscle (SK), however, reflect more extreme differences (low and high,
respectively) and are not corrected. N, no template control; KCL,
plasmids from KC cDNA library; LV, liver; KD, kidney; PN, pancreas; PC,
placenta; BR, brain; HT, heart. Weakest intensities in skeletal muscle,
kidney, and brain do not reproduce well but were faintly visible in the
original gel. (d) Single PCR band (arrowhead primers) from human gen-
omic DNA. LD, ladder (1000, 850, and 650 bp). , no template; GN,
genomic DNA. The 794 bp band size matches the length predicted
from GenBank sequence for chromosome 10.
Figure S3
COPR1 and COPR2 contain an autonomous activation domain. (a)
Mammalian one-hybrid analysis was performed in transfected COS-7
cells for transcriptional activation of a Gal4 UAS CAT reporter construct.
First two bars, COPR1 or COPR2 were fused in-frame to the Gal4 DNA-
binding domain (pM vector). There was no detectable expression from
the parental pM vector. CAT reporter activation by COPR2 was set to
100%. Third bar, cotransfection of pM-53 and pVP16-SV40 T antigen
plasmids provides a signal for comparison of transcriptional activation
by COPR constructs. Data presented is the mean  the standard de-
viation (SD) of triplicate samples and is representative of at least three
independent transfections. (b) Yeast one-hybrid analysis. COPR1 or
COPR2 were fused in-frame with the Gal4 DNA-binding domain in the
pGBKT7 yeast expression vector. There was no detectable expression
from the parental pGBKT7 vector. SD values from triplicate cultures
were o5% and are not included on the bars. A representative exper-
iment of at least three independent runs is shown. As in (a), reporter
activation by COPR2 was set to 100%. (c) Diagrammatic representation
of truncation and site-directed mutants used in (d). Each cDNA was
fused in-frame to the carboxyl terminus of the Gal4 DNA binding do-
main in pGBKT7. For simplicity, only the COPR portion of the construct
is shown. WT, wild-type. The vertical line in COPR1 represents the
relative location of the additional 50 amino acids in COPR2. The five
solid circles represent the five leucines in the predicted leucine zipper.
The hatched region at the C-terminus represents the proline-acid-rich
(PAR) domain. ES1, early stop truncation mutant 1, deletes the leucine
ziper and PAR. ES2, early stop truncation mutant 2, deletes just the
PAR. 2,3Z, is a leucine zipper site-directed mutant with the second and
third leucine residues changed to alanines (open circles). For COPR2,
the abbreviations and designations are the same with the addition of
the gray region to denote the additional 50 amino acids. (d) WT and
mutant constructs described in c were assayed for reporter gene ac-
tivation via one-hybrid assay in yeast AH109. Activation by WT COPR2
was set at 100% for a relative comparison. Deletion of the PAR co-
incided with loss of most of the transcriptional activation by either
COPR1 or COPR2. Reporter activation by the leucine zipper mutant
(2,3Z) of either COPR1 or COPR2 was significantly increased compared
to its respective WT construct, Student’s t test, po0.05.
Figure S4
Ligand effect on PPAR interaction with COPR1 and COPR2. AH109
yeast transformed with the indicated PPAR isoform expressed from
pGBKT7 were mated to Y187 yeast transformed with COPR1 or 2 ex-
pressed from pGAD10. Diploid progeny were assayed for b-gala-
ctosidase activity normalized to number of yeast cells. Media contained
either vehicle (DM, DMSO, final concentration 0.1%) or ligand (LG) for
the respective receptors, PPARa, 10 mM WY14,643; PPARd, 3 mM
cPGI2; PPARg, 10 mM troglitazone. Lamin control received 10 mM
WY14,643. Data presented is the mean  SD of triplicate samples and
is representative of at least three independent assays. SD valueso5%
are not included on the bars.
FigureS5
COPR1 with peroxisome proliferator activated receptors (PPAR)
provides better growth rescue than COPR2. Y187 yeast expressing
COPR1 or COPR2 from pGAD10 were mated with AH109 yeast ex-
pressing PPARa, d, g, or lamin C from pGBKT7. Diploid progeny were
plated onto triple (-Leu/-Trp/-His) or quadruple dropout (-Leu/-Trp/-
His/-Ade) media and cultured at 301C for 4 d. Replicate patches are
shown for the quadruple dropout media where growth was more varied.
Data presented are representative of growth habit from at least two
independent transformations. The faint haze present for lamin and
COPR2:PPARg indicates remnant of original inoculum spotted on plate.
Figure S6
Interaction of COPR1 and COPR2 with preferred nuclear receptors
is NR box dependent. Yeast two-hybrid b-galactosidase activity was
determined as in Fig S4 following coexpression of either NR box WT or
LLYAA mutants (AA) of COPR1 or COPR2 with PPARa, RXRa, or lamin
C. Yeast were grown in media with vehicle (DM, DMSO, final concen-
tration 0.1%) or ligand (LG) for the PPARa, 10 mM WY14,643 or RXRa, 1
mM 9-cis RA. The break in the ordinate axis accommodates high activity
from the COPR1:RXRa interaction in the presence of ligand. Coex-
pression of wild-type or LLYAA mutants of COPR1 or COPR2 with lamin
C cultured in the presence of WY14,643 served as a negative control.
Figure S7
Expression of COPR1 decreases PPARa/RXRa-mediated activation
of an involucrin promoter-reporter. COS-7 cells were transfected
with a 3700-involucrin promoter CAT reporter construct alone or with
pSG5 mammalian expression vector containing no insert () or cDNA
(þ ) for human PPARa and RXRa (Pa/Ra) along with the mammalian
expression vector pcDNA3.1þ containing no insert () or the COPR1
cDNA (as indicated on graph). Cultures received either vehicle- (,
0.1% DMSO) or ligand-supplemented (þ , 10 mM WY) media.
Transfection of wild-type COPR1 (0.9 mg) in the absence of hetero-
dimer coexpression (second pair of bars) had no detectable effect on
the reporter. Other transfections included wild-type COPR1 (0.3 or 0.9
mg, 0.3 and 0.9 WT, respectively, on graph) or the double alanine (AA)
COPR1 mutant at the higher 0.9 mg amount. Total plasmid amounts
were normalized by addition of empty expression vector. Student’s t
test (po0.005; po0.001) was used for pairwise comparisons indi-
cated on graph.
FigureS8
Physical association of COPR1 and COPR2 with retinoid X recep-
tors (RXR)a. COS-7 cells were cotransfected with HA-tagged COPR1
or HA-tagged COPR2 and myc-tagged RXRa or their respective AA
mutants in the mammalian expression vector pCMV. Cell lysates were
immunoprecipitated (IP) with anti-HA antibody and recovered com-
plexes were immunoblotted (IB) with anti-myc antibody. Blots were
stripped and reprobed with anti-HA antibody to determine relative
amount of COPR1 or COPR2 present in each immunocomplex. Chemi-
luminescence was detected with a CCD camera and band intensities
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were determined with Kodak 1D Image analysis software directly from
the original signal. The HA signal of each lane was used to normalize
the coprecipitated RXRa signal for that lane.
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